Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders

This publication has 31 references indexed in Scilit:

• EndocrinologyHormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix)
  Human Reproduction, 1996
• High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome
  Fertility and Sterility, 1996
• Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages
  Journal of Assisted Reproduction and Genetics, 1996
• The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program
  Fertility and Sterility, 1994
• Hormonal responses to the new potent GnRH antagonist Cetrorelix
  Acta Endocrinologica, 1993
• Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization
  Human Reproduction, 1991
• Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels
  Fertility and Sterility, 1991
• An alternate approach to controlled ovarian hyperstimulation in “poor responders”: pretreatment with a gonadotropin-releasing hormone analog
  Fertility and Sterility, 1988
• The importance of the follicular phase to success and failure in in vitro fertilization
  Fertility and Sterility, 1983
• The effect of luteinizing hormone-releasing factor and its agonist on cultured human granulosa cells
  Fertility and Sterility, 1982